For more information, please contact:
China Shenghuo Pharmaceutical Holdings, Inc.
Mr. Changhua Mu
Securities Affairs Representative
Email: c.mu@chinashenghuo.net
Grayling
Eddie Cheung
Investor Relations
Tel: +1-646-284-9414
Email: eddie.cheung@us.grayling.com
China Shenghuo Pharmaceutical Holdings, Inc.
Condensed Consolidated Balance Sheets
(Unaudited)
March 31, December 31,
2009 2008
ASSETS:
Current Assets:
Cash and cash equivalents $908,596 $1,612,054
Accounts and notes receivable, less
allowance for doubtful
accounts of $4,949,009 and $4,834,745,
respectively 10,490,378 9,108,703
Sales representative advances, less
allowance for doubtful
accounts of $3,026,086 and $2,955,516,
respectively 7,453,244 8,637,653
Advances to suppliers 508,627 446,168
Inventory, net of reserve for obsolescence
of $148,163 and
$147,978, respectively 3,784,385 4,287,462
Other current assets 31,714 41,177
Total Current Assets 23,176,944 24,133,217
Property, plant and equipment, net of
accumulated
'/>"/>
| SOURCE China Shenghuo Pharmaceutical Holdings, Inc. Copyright©2009 PR Newswire. All rights reserved |